Verve Therapeutics Overview
Verve Therapeutics (VERV) has a PEG ratio of 12.98, above the Healthcare sector average of 2.89.
Get informed when a big investor buys or sells
+ Follow12.98
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
As of the most recent data, VERV shows a PEG ratio of 12.98. That is above the Healthcare sector average of 2.89. Scroll down for historical charts and peer comparison views.
The Healthcare sector average PEG ratio is about 2.89. Verve Therapeutics is at 12.98, which is higher that average. That is roughly 349.1% above the sector mean. Use the comparison chart on this page to see how VERV stacks up against individual peers as well.
Investors watch VERV's PEG ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Verve Therapeutics's latest reading is 12.98. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this peg ratio page, Stockcircle has Verve Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect PEG ratio (currently 12.98) with ownership activity and broader fundamentals.
The Healthcare average PEG ratio is about 2.89, while VERV is at 12.98. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
